FDA Panel to Consider Sex Patch for Women
407285
Depending on whom you ask, Procter &amp; Gamble&#39;s new female testosterone patch is either a medical marvel that will change women&#39;s lives or a potentially dangerous
763100
Procter & Gamble Co. PG.N said on  Tuesday U.S. regulators have granted priority review for its  experimental drug to treat reduced sex drive in women with  menopause triggered by surgery.
114766
Proctor &amp; Gamble, the company behind a testosterone patch called Intrinsa, hoped to have the first female Viagra equivalient on the market but after reviewing the research, an FDA advisory committee said &quot;no&quot;.
152446
Questions about the effectiveness and long-term safety of a testosterone patch designed to boost a woman's sex drive has federal regulators wondering whether to approve the product at all.
552877
A Procter &amp; Gamble officials told federal health advisers today that a hormone patch aimed at restoring women&#39;s lost libido has not been linked to any serious safety problems.
226079
NEW YORK  - Treatment with an ultralow-dose  of the hormone estradiol, administered as a patch, reduces the  rate of bone loss in older women without promoting the build-up  of cells in the uterine lining, which is associated with an  increased risk of cancer, according to a new report.
100913
Treatment with an ultralow-dose of the hormone estradiol, administered as a patch, reduces the rate of bone loss in older women without promoting the build-up of cells in the uterine lining, which is associated with an increased risk of cancer, according to a new report.
20582
WASHINGTON : A skin patch providing sexual stimulation for menopausal women that promises to do what Viagra did for men will begin its approval procedure on Thursday at the Federal Drug Administration (FDA).
664086
NEW YORK  - Women who use a contraceptive patch appear to be more than twice as likely to develop a dangerous blood clot in their veins as those who use an oral contraceptive, new research shows.
410491
GAITHERSBURG, Md.  - Procter & Gamble Co.'s  testosterone patch for boosting female sex drive needs  longer-term testing for serious side effects before it can win  approval, a U.S. advisory panel unanimously ruled on Thursday.
593660
Despite recent hoopla over a testosterone patch, female sexuality is so complex that a single drug may not help most women on the dysfunction front. By Randy Dotinga.
68174
The US Food and Drug Administration announced Tuesday that it has set up a national registry to follow women of childbearing age who are prescribed the acne drug Accutane
326682
Federal health advisers are refusing to recommend a hormone patch that works to restore a woman&#39;s sex drive. An advisory committee says the patch, called Intrinsa, shouldn&#39;t win government approval until more
687565
NEW YORK - A US Food and Drug Administration advisory panel rejected Procter &amp; Gamble&#39;s testosterone patch to treat female sexual dysfunction.
475875
The risk of blood clots in the legs and lungs may be higher for women using the birth-control patch instead of the pill, according to a warning on the product's label disclosed Wednesday.
572559
A House of Representatives subcommittee is expected to take up legislation next week meant to bolster the Food and Drug Administration's ability to monitor prescription drug side effects, the panel's chairman said in a letter released on Thursday.
471279
The Thursday night rejection of Proctor &amp; Gamble&#39;s (PG:NYSE - news - research) female testosterone sex-drive patch Intrinsa by a Food and Drug Administration advisory panel will almost certainly delay efforts by BioSante to develop its own product, a